Danish drugmaker Novo Nordisk says it is ready to release a cheaper copy of its Ozempic diabetes medication, but hasn’t yet given a price.

Danish drugmaker Novo Nordisk says it is ready to release a cheaper copy of its Ozempic diabetes medication, but hasn’t yet given a price.

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.